nodes	percent_of_prediction	percent_of_DWPC	metapath
Amantadine—SLC22A1—obesity	0.218	0.634	CbGaD
Amantadine—MAOB—Phentermine—obesity	0.163	0.413	CbGbCtD
Amantadine—MAOB—Methamphetamine—obesity	0.13	0.33	CbGbCtD
Amantadine—DRD2—obesity	0.126	0.366	CbGaD
Amantadine—SLC22A2—Cimetidine—obesity	0.0474	0.12	CbGbCtD
Amantadine—SLC22A1—Cimetidine—obesity	0.0412	0.104	CbGbCtD
Amantadine—ABCB1—Cimetidine—obesity	0.0126	0.032	CbGbCtD
Amantadine—GRIN2C—hindbrain—obesity	0.00308	0.0854	CbGeAlD
Amantadine—GRIN2D—hindbrain—obesity	0.00286	0.0794	CbGeAlD
Amantadine—GRIN1—hindbrain—obesity	0.00255	0.0707	CbGeAlD
Amantadine—GRIN2B—hindbrain—obesity	0.00244	0.0675	CbGeAlD
Amantadine—GRIN2A—hindbrain—obesity	0.00213	0.059	CbGeAlD
Amantadine—DDC—hindbrain—obesity	0.00199	0.0551	CbGeAlD
Amantadine—GRIN2C—adrenal cortex—obesity	0.00158	0.0438	CbGeAlD
Amantadine—DDC—respiratory system—obesity	0.00121	0.0337	CbGeAlD
Amantadine—MAOB—hindbrain—obesity	0.00102	0.0284	CbGeAlD
Amantadine—DRD2—hindbrain—obesity	0.000864	0.0239	CbGeAlD
Amantadine—GRIN1—endocrine gland—obesity	0.000819	0.0227	CbGeAlD
Amantadine—GRIN2A—adrenal gland—obesity	0.000788	0.0218	CbGeAlD
Amantadine—GRIN2B—endocrine gland—obesity	0.000782	0.0217	CbGeAlD
Amantadine—DDC—adrenal gland—obesity	0.000736	0.0204	CbGeAlD
Amantadine—SIGMAR1—islet of Langerhans—obesity	0.000691	0.0192	CbGeAlD
Amantadine—GRIN2A—endocrine gland—obesity	0.000683	0.0189	CbGeAlD
Amantadine—DDC—endocrine gland—obesity	0.000638	0.0177	CbGeAlD
Amantadine—SLC22A2—digestive system—obesity	0.000636	0.0176	CbGeAlD
Amantadine—MAOB—respiratory system—obesity	0.000625	0.0173	CbGeAlD
Amantadine—DDC—liver—obesity	0.000575	0.0159	CbGeAlD
Amantadine—SIGMAR1—adrenal cortex—obesity	0.000548	0.0152	CbGeAlD
Amantadine—DRD2—respiratory system—obesity	0.000527	0.0146	CbGeAlD
Amantadine—MAOB—adrenal cortex—obesity	0.000525	0.0145	CbGeAlD
Amantadine—MAOB—cardiovascular system—obesity	0.000479	0.0133	CbGeAlD
Amantadine—SLC22A1—adipose tissue—obesity	0.000477	0.0132	CbGeAlD
Amantadine—SIGMAR1—pituitary gland—obesity	0.000443	0.0123	CbGeAlD
Amantadine—SIGMAR1—adipose tissue—obesity	0.000441	0.0122	CbGeAlD
Amantadine—MAOB—pituitary gland—obesity	0.000424	0.0117	CbGeAlD
Amantadine—MAOB—adipose tissue—obesity	0.000422	0.0117	CbGeAlD
Amantadine—MAOB—digestive system—obesity	0.000397	0.011	CbGeAlD
Amantadine—SIGMAR1—adrenal gland—obesity	0.000396	0.011	CbGeAlD
Amantadine—MAOB—adrenal gland—obesity	0.000379	0.0105	CbGeAlD
Amantadine—SLC22A1—endocrine gland—obesity	0.000371	0.0103	CbGeAlD
Amantadine—DRD2—pituitary gland—obesity	0.000358	0.00991	CbGeAlD
Amantadine—SLC22A1—liver—obesity	0.000335	0.00927	CbGeAlD
Amantadine—MAOB—endocrine gland—obesity	0.000328	0.0091	CbGeAlD
Amantadine—SIGMAR1—liver—obesity	0.000309	0.00857	CbGeAlD
Amantadine—MAOB—liver—obesity	0.000296	0.0082	CbGeAlD
Amantadine—DRD2—endocrine gland—obesity	0.000277	0.00768	CbGeAlD
Amantadine—Constipation—Cimetidine—obesity	0.000253	0.00178	CcSEcCtD
Amantadine—Gait disturbance—Topiramate—obesity	0.000252	0.00178	CcSEcCtD
Amantadine—Dizziness—Phenylpropanolamine—obesity	0.000247	0.00174	CcSEcCtD
Amantadine—Diarrhoea—Phentermine—obesity	0.000244	0.00172	CcSEcCtD
Amantadine—Feeling abnormal—Cimetidine—obesity	0.000244	0.00172	CcSEcCtD
Amantadine—Dysphagia—Bupropion—obesity	0.000242	0.00171	CcSEcCtD
Amantadine—ABCB1—islet of Langerhans—obesity	0.000241	0.00669	CbGeAlD
Amantadine—Depressed level of consciousness—Topiramate—obesity	0.000238	0.00167	CcSEcCtD
Amantadine—Urinary incontinence—Topiramate—obesity	0.000238	0.00167	CcSEcCtD
Amantadine—Vomiting—Phenylpropanolamine—obesity	0.000237	0.00167	CcSEcCtD
Amantadine—Dizziness—Phentermine—obesity	0.000236	0.00167	CcSEcCtD
Amantadine—Sweating increased—Bupropion—obesity	0.000236	0.00166	CcSEcCtD
Amantadine—Rash—Phenylpropanolamine—obesity	0.000235	0.00166	CcSEcCtD
Amantadine—Dermatitis—Phenylpropanolamine—obesity	0.000235	0.00166	CcSEcCtD
Amantadine—Body temperature increased—Cimetidine—obesity	0.000234	0.00165	CcSEcCtD
Amantadine—ABCB1—respiratory system—obesity	0.000228	0.00632	CbGeAlD
Amantadine—Vomiting—Phentermine—obesity	0.000227	0.0016	CcSEcCtD
Amantadine—Urinary tract disorder—Orlistat—obesity	0.000227	0.0016	CcSEcCtD
Amantadine—Oedema peripheral—Orlistat—obesity	0.000226	0.0016	CcSEcCtD
Amantadine—Urethral disorder—Orlistat—obesity	0.000225	0.00159	CcSEcCtD
Amantadine—Rash—Phentermine—obesity	0.000225	0.00159	CcSEcCtD
Amantadine—Dermatitis—Phentermine—obesity	0.000225	0.00159	CcSEcCtD
Amantadine—Headache—Phentermine—obesity	0.000224	0.00158	CcSEcCtD
Amantadine—Nausea—Phenylpropanolamine—obesity	0.000222	0.00156	CcSEcCtD
Amantadine—Photosensitivity reaction—Bupropion—obesity	0.000221	0.00156	CcSEcCtD
Amantadine—Oedema peripheral—Sibutramine—obesity	0.000219	0.00154	CcSEcCtD
Amantadine—Hypersensitivity—Cimetidine—obesity	0.000218	0.00154	CcSEcCtD
Amantadine—Hypertonia—Topiramate—obesity	0.000216	0.00152	CcSEcCtD
Amantadine—Hyperkinesia—Topiramate—obesity	0.000215	0.00151	CcSEcCtD
Amantadine—Visual impairment—Sibutramine—obesity	0.000214	0.00151	CcSEcCtD
Amantadine—Mental disability—Topiramate—obesity	0.000213	0.00151	CcSEcCtD
Amantadine—Diarrhoea—Diethylpropion—obesity	0.000213	0.0015	CcSEcCtD
Amantadine—Nausea—Phentermine—obesity	0.000212	0.0015	CcSEcCtD
Amantadine—Asthenia—Cimetidine—obesity	0.000212	0.0015	CcSEcCtD
Amantadine—Euphoric mood—Topiramate—obesity	0.000211	0.00149	CcSEcCtD
Amantadine—Eye disorder—Sibutramine—obesity	0.000208	0.00147	CcSEcCtD
Amantadine—Mediastinal disorder—Orlistat—obesity	0.000207	0.00146	CcSEcCtD
Amantadine—Dizziness—Diethylpropion—obesity	0.000206	0.00145	CcSEcCtD
Amantadine—Alopecia—Orlistat—obesity	0.000203	0.00143	CcSEcCtD
Amantadine—Diarrhoea—Cimetidine—obesity	0.000202	0.00143	CcSEcCtD
Amantadine—Angiopathy—Sibutramine—obesity	0.000202	0.00142	CcSEcCtD
Amantadine—Mental disorder—Orlistat—obesity	0.000201	0.00142	CcSEcCtD
Amantadine—Malnutrition—Orlistat—obesity	0.0002	0.00141	CcSEcCtD
Amantadine—Disorientation—Topiramate—obesity	0.0002	0.00141	CcSEcCtD
Amantadine—Eczema—Topiramate—obesity	0.000199	0.0014	CcSEcCtD
Amantadine—Arrhythmia—Sibutramine—obesity	0.000199	0.0014	CcSEcCtD
Amantadine—Vomiting—Diethylpropion—obesity	0.000198	0.00139	CcSEcCtD
Amantadine—Alopecia—Sibutramine—obesity	0.000197	0.00139	CcSEcCtD
Amantadine—Rash—Diethylpropion—obesity	0.000196	0.00138	CcSEcCtD
Amantadine—Dermatitis—Diethylpropion—obesity	0.000196	0.00138	CcSEcCtD
Amantadine—Dizziness—Cimetidine—obesity	0.000196	0.00138	CcSEcCtD
Amantadine—Headache—Diethylpropion—obesity	0.000195	0.00137	CcSEcCtD
Amantadine—Malnutrition—Sibutramine—obesity	0.000194	0.00137	CcSEcCtD
Amantadine—Hallucination—Bupropion—obesity	0.000193	0.00136	CcSEcCtD
Amantadine—Libido decreased—Topiramate—obesity	0.000193	0.00136	CcSEcCtD
Amantadine—Urinary tract disorder—Bupropion—obesity	0.000192	0.00135	CcSEcCtD
Amantadine—ABCB1—adrenal cortex—obesity	0.000191	0.0053	CbGeAlD
Amantadine—Oedema peripheral—Bupropion—obesity	0.000191	0.00135	CcSEcCtD
Amantadine—Urethral disorder—Bupropion—obesity	0.00019	0.00134	CcSEcCtD
Amantadine—Amnesia—Topiramate—obesity	0.00019	0.00134	CcSEcCtD
Amantadine—Tension—Sibutramine—obesity	0.00019	0.00134	CcSEcCtD
Amantadine—Vision blurred—Orlistat—obesity	0.000189	0.00133	CcSEcCtD
Amantadine—Visual disturbance—Topiramate—obesity	0.000188	0.00133	CcSEcCtD
Amantadine—Nervousness—Sibutramine—obesity	0.000188	0.00133	CcSEcCtD
Amantadine—Vomiting—Cimetidine—obesity	0.000188	0.00133	CcSEcCtD
Amantadine—Visual impairment—Bupropion—obesity	0.000187	0.00132	CcSEcCtD
Amantadine—Rash—Cimetidine—obesity	0.000186	0.00131	CcSEcCtD
Amantadine—Dermatitis—Cimetidine—obesity	0.000186	0.00131	CcSEcCtD
Amantadine—Headache—Cimetidine—obesity	0.000185	0.00131	CcSEcCtD
Amantadine—Nausea—Diethylpropion—obesity	0.000185	0.0013	CcSEcCtD
Amantadine—Vision blurred—Sibutramine—obesity	0.000182	0.00129	CcSEcCtD
Amantadine—Lethargy—Topiramate—obesity	0.000182	0.00128	CcSEcCtD
Amantadine—Tremor—Sibutramine—obesity	0.000181	0.00128	CcSEcCtD
Amantadine—Eye disorder—Bupropion—obesity	0.000181	0.00128	CcSEcCtD
Amantadine—Cardiac disorder—Bupropion—obesity	0.00018	0.00127	CcSEcCtD
Amantadine—Osteoarthritis—Topiramate—obesity	0.000179	0.00126	CcSEcCtD
Amantadine—Agitation—Sibutramine—obesity	0.000178	0.00125	CcSEcCtD
Amantadine—Disturbance in sexual arousal—Topiramate—obesity	0.000177	0.00125	CcSEcCtD
Amantadine—Palpitations—Orlistat—obesity	0.000177	0.00125	CcSEcCtD
Amantadine—Angiopathy—Bupropion—obesity	0.000176	0.00124	CcSEcCtD
Amantadine—Nausea—Cimetidine—obesity	0.000176	0.00124	CcSEcCtD
Amantadine—Mediastinal disorder—Bupropion—obesity	0.000175	0.00123	CcSEcCtD
Amantadine—ABCB1—cardiovascular system—obesity	0.000175	0.00484	CbGeAlD
Amantadine—Psychotic disorder—Topiramate—obesity	0.000174	0.00123	CcSEcCtD
Amantadine—Convulsion—Orlistat—obesity	0.000173	0.00122	CcSEcCtD
Amantadine—Leukopenia—Sibutramine—obesity	0.000173	0.00122	CcSEcCtD
Amantadine—Arrhythmia—Bupropion—obesity	0.000173	0.00122	CcSEcCtD
Amantadine—Alopecia—Bupropion—obesity	0.000171	0.00121	CcSEcCtD
Amantadine—Palpitations—Sibutramine—obesity	0.000171	0.00121	CcSEcCtD
Amantadine—Irritability—Topiramate—obesity	0.00017	0.0012	CcSEcCtD
Amantadine—Mental disorder—Bupropion—obesity	0.00017	0.0012	CcSEcCtD
Amantadine—Urinary retention—Topiramate—obesity	0.00017	0.0012	CcSEcCtD
Amantadine—Anxiety—Orlistat—obesity	0.00017	0.0012	CcSEcCtD
Amantadine—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	0.000169	0.00119	CcSEcCtD
Amantadine—Malnutrition—Bupropion—obesity	0.000169	0.00119	CcSEcCtD
Amantadine—Ataxia—Topiramate—obesity	0.000168	0.00118	CcSEcCtD
Amantadine—Convulsion—Sibutramine—obesity	0.000168	0.00118	CcSEcCtD
Amantadine—Hypertension—Sibutramine—obesity	0.000167	0.00118	CcSEcCtD
Amantadine—Dry mouth—Orlistat—obesity	0.000167	0.00117	CcSEcCtD
Amantadine—Tension—Bupropion—obesity	0.000166	0.00117	CcSEcCtD
Amantadine—Liver function test abnormal—Topiramate—obesity	0.000165	0.00116	CcSEcCtD
Amantadine—Anxiety—Sibutramine—obesity	0.000164	0.00116	CcSEcCtD
Amantadine—Nervousness—Bupropion—obesity	0.000164	0.00116	CcSEcCtD
Amantadine—Oedema—Orlistat—obesity	0.000163	0.00115	CcSEcCtD
Amantadine—Anaphylactic shock—Orlistat—obesity	0.000163	0.00115	CcSEcCtD
Amantadine—Orthostatic hypotension—Topiramate—obesity	0.000163	0.00115	CcSEcCtD
Amantadine—Dry mouth—Sibutramine—obesity	0.000161	0.00114	CcSEcCtD
Amantadine—Nervous system disorder—Orlistat—obesity	0.00016	0.00113	CcSEcCtD
Amantadine—Confusional state—Sibutramine—obesity	0.000159	0.00112	CcSEcCtD
Amantadine—Vision blurred—Bupropion—obesity	0.000159	0.00112	CcSEcCtD
Amantadine—Skin disorder—Orlistat—obesity	0.000159	0.00112	CcSEcCtD
Amantadine—Tremor—Bupropion—obesity	0.000158	0.00112	CcSEcCtD
Amantadine—Anaphylactic shock—Sibutramine—obesity	0.000158	0.00111	CcSEcCtD
Amantadine—Oedema—Sibutramine—obesity	0.000158	0.00111	CcSEcCtD
Amantadine—Hyperhidrosis—Orlistat—obesity	0.000158	0.00111	CcSEcCtD
Amantadine—Agitation—Bupropion—obesity	0.000155	0.00109	CcSEcCtD
Amantadine—ABCB1—pituitary gland—obesity	0.000155	0.00428	CbGeAlD
Amantadine—Dysphagia—Topiramate—obesity	0.000154	0.00109	CcSEcCtD
Amantadine—Tachycardia—Sibutramine—obesity	0.000154	0.00109	CcSEcCtD
Amantadine—ABCB1—adipose tissue—obesity	0.000154	0.00427	CbGeAlD
Amantadine—Skin disorder—Sibutramine—obesity	0.000154	0.00108	CcSEcCtD
Amantadine—Hyperhidrosis—Sibutramine—obesity	0.000153	0.00108	CcSEcCtD
Amantadine—Leukopenia—Bupropion—obesity	0.000151	0.00107	CcSEcCtD
Amantadine—Anorexia—Sibutramine—obesity	0.000151	0.00106	CcSEcCtD
Amantadine—Sweating increased—Topiramate—obesity	0.00015	0.00106	CcSEcCtD
Amantadine—Palpitations—Bupropion—obesity	0.000149	0.00105	CcSEcCtD
Amantadine—Insomnia—Orlistat—obesity	0.000148	0.00104	CcSEcCtD
Amantadine—Hypotension—Sibutramine—obesity	0.000148	0.00104	CcSEcCtD
Amantadine—Paraesthesia—Orlistat—obesity	0.000147	0.00103	CcSEcCtD
Amantadine—Convulsion—Bupropion—obesity	0.000146	0.00103	CcSEcCtD
Amantadine—Hypertension—Bupropion—obesity	0.000146	0.00103	CcSEcCtD
Amantadine—ABCB1—digestive system—obesity	0.000145	0.00402	CbGeAlD
Amantadine—Neutropenia—Topiramate—obesity	0.000144	0.00102	CcSEcCtD
Amantadine—Dyspepsia—Orlistat—obesity	0.000144	0.00101	CcSEcCtD
Amantadine—Anxiety—Bupropion—obesity	0.000143	0.00101	CcSEcCtD
Amantadine—Insomnia—Sibutramine—obesity	0.000143	0.00101	CcSEcCtD
Amantadine—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	0.000143	0.00101	CcSEcCtD
Amantadine—Decreased appetite—Orlistat—obesity	0.000142	0.001	CcSEcCtD
Amantadine—Paraesthesia—Sibutramine—obesity	0.000142	0.001	CcSEcCtD
Amantadine—Gastrointestinal disorder—Orlistat—obesity	0.000141	0.000994	CcSEcCtD
Amantadine—Dyspnoea—Sibutramine—obesity	0.000141	0.000993	CcSEcCtD
Amantadine—Photosensitivity reaction—Topiramate—obesity	0.000141	0.000993	CcSEcCtD
Amantadine—Fatigue—Orlistat—obesity	0.000141	0.000993	CcSEcCtD
Amantadine—Dry mouth—Bupropion—obesity	0.000141	0.000991	CcSEcCtD
Amantadine—Somnolence—Sibutramine—obesity	0.00014	0.00099	CcSEcCtD
Amantadine—Dyspepsia—Sibutramine—obesity	0.000139	0.000981	CcSEcCtD
Amantadine—Confusional state—Bupropion—obesity	0.000139	0.000979	CcSEcCtD
Amantadine—ABCB1—adrenal gland—obesity	0.000138	0.00383	CbGeAlD
Amantadine—Anaphylactic shock—Bupropion—obesity	0.000138	0.000971	CcSEcCtD
Amantadine—Oedema—Bupropion—obesity	0.000138	0.000971	CcSEcCtD
Amantadine—Decreased appetite—Sibutramine—obesity	0.000137	0.000969	CcSEcCtD
Amantadine—Gastrointestinal disorder—Sibutramine—obesity	0.000136	0.000962	CcSEcCtD
Amantadine—Constipation—Sibutramine—obesity	0.000135	0.000953	CcSEcCtD
Amantadine—Nervous system disorder—Bupropion—obesity	0.000135	0.000953	CcSEcCtD
Amantadine—Feeling abnormal—Orlistat—obesity	0.000135	0.000949	CcSEcCtD
Amantadine—Tachycardia—Bupropion—obesity	0.000134	0.000948	CcSEcCtD
Amantadine—Skin disorder—Bupropion—obesity	0.000134	0.000943	CcSEcCtD
Amantadine—Hyperhidrosis—Bupropion—obesity	0.000133	0.000939	CcSEcCtD
Amantadine—Anorexia—Bupropion—obesity	0.000131	0.000926	CcSEcCtD
Amantadine—Feeling abnormal—Sibutramine—obesity	0.00013	0.000918	CcSEcCtD
Amantadine—Body temperature increased—Orlistat—obesity	0.000129	0.00091	CcSEcCtD
Amantadine—Hypotension—Bupropion—obesity	0.000129	0.000908	CcSEcCtD
Amantadine—Agranulocytosis—Topiramate—obesity	0.000128	0.000905	CcSEcCtD
Amantadine—Body temperature increased—Sibutramine—obesity	0.000125	0.000881	CcSEcCtD
Amantadine—Insomnia—Bupropion—obesity	0.000125	0.000878	CcSEcCtD
Amantadine—Paraesthesia—Bupropion—obesity	0.000124	0.000872	CcSEcCtD
Amantadine—Hallucination—Topiramate—obesity	0.000123	0.000867	CcSEcCtD
Amantadine—Dyspnoea—Bupropion—obesity	0.000123	0.000866	CcSEcCtD
Amantadine—Somnolence—Bupropion—obesity	0.000122	0.000863	CcSEcCtD
Amantadine—Urinary tract disorder—Topiramate—obesity	0.000122	0.00086	CcSEcCtD
Amantadine—Oedema peripheral—Topiramate—obesity	0.000122	0.000858	CcSEcCtD
Amantadine—Dyspepsia—Bupropion—obesity	0.000121	0.000855	CcSEcCtD
Amantadine—Urethral disorder—Topiramate—obesity	0.000121	0.000854	CcSEcCtD
Amantadine—Hypersensitivity—Orlistat—obesity	0.00012	0.000848	CcSEcCtD
Amantadine—Decreased appetite—Bupropion—obesity	0.00012	0.000844	CcSEcCtD
Amantadine—ABCB1—endocrine gland—obesity	0.00012	0.00332	CbGeAlD
Amantadine—Visual impairment—Topiramate—obesity	0.000119	0.000839	CcSEcCtD
Amantadine—Gastrointestinal disorder—Bupropion—obesity	0.000119	0.000839	CcSEcCtD
Amantadine—Fatigue—Bupropion—obesity	0.000119	0.000837	CcSEcCtD
Amantadine—Constipation—Bupropion—obesity	0.000118	0.000831	CcSEcCtD
Amantadine—Asthenia—Orlistat—obesity	0.000117	0.000826	CcSEcCtD
Amantadine—Hypersensitivity—Sibutramine—obesity	0.000116	0.000821	CcSEcCtD
Amantadine—Pruritus—Orlistat—obesity	0.000116	0.000814	CcSEcCtD
Amantadine—Eye disorder—Topiramate—obesity	0.000115	0.000814	CcSEcCtD
Amantadine—Cardiac disorder—Topiramate—obesity	0.000115	0.000808	CcSEcCtD
Amantadine—Feeling abnormal—Bupropion—obesity	0.000114	0.0008	CcSEcCtD
Amantadine—Asthenia—Sibutramine—obesity	0.000113	0.000799	CcSEcCtD
Amantadine—Angiopathy—Topiramate—obesity	0.000112	0.00079	CcSEcCtD
Amantadine—Pruritus—Sibutramine—obesity	0.000112	0.000788	CcSEcCtD
Amantadine—Diarrhoea—Orlistat—obesity	0.000112	0.000788	CcSEcCtD
Amantadine—Mediastinal disorder—Topiramate—obesity	0.000111	0.000785	CcSEcCtD
Amantadine—Alopecia—Topiramate—obesity	0.000109	0.00077	CcSEcCtD
Amantadine—Body temperature increased—Bupropion—obesity	0.000109	0.000768	CcSEcCtD
Amantadine—Mental disorder—Topiramate—obesity	0.000108	0.000763	CcSEcCtD
Amantadine—Diarrhoea—Sibutramine—obesity	0.000108	0.000762	CcSEcCtD
Amantadine—Dizziness—Orlistat—obesity	0.000108	0.000761	CcSEcCtD
Amantadine—ABCB1—liver—obesity	0.000108	0.00299	CbGeAlD
Amantadine—Malnutrition—Topiramate—obesity	0.000108	0.000758	CcSEcCtD
Amantadine—Tension—Topiramate—obesity	0.000106	0.000744	CcSEcCtD
Amantadine—Dizziness—Sibutramine—obesity	0.000105	0.000737	CcSEcCtD
Amantadine—Nervousness—Topiramate—obesity	0.000104	0.000736	CcSEcCtD
Amantadine—Vomiting—Orlistat—obesity	0.000104	0.000732	CcSEcCtD
Amantadine—Rash—Orlistat—obesity	0.000103	0.000726	CcSEcCtD
Amantadine—Dermatitis—Orlistat—obesity	0.000103	0.000725	CcSEcCtD
Amantadine—Headache—Orlistat—obesity	0.000102	0.000721	CcSEcCtD
Amantadine—Hypersensitivity—Bupropion—obesity	0.000102	0.000716	CcSEcCtD
Amantadine—Vision blurred—Topiramate—obesity	0.000101	0.000715	CcSEcCtD
Amantadine—Tremor—Topiramate—obesity	0.000101	0.00071	CcSEcCtD
Amantadine—Vomiting—Sibutramine—obesity	0.0001	0.000708	CcSEcCtD
Amantadine—Rash—Sibutramine—obesity	9.96e-05	0.000702	CcSEcCtD
Amantadine—Dermatitis—Sibutramine—obesity	9.96e-05	0.000702	CcSEcCtD
Amantadine—Headache—Sibutramine—obesity	9.9e-05	0.000698	CcSEcCtD
Amantadine—Asthenia—Bupropion—obesity	9.88e-05	0.000697	CcSEcCtD
Amantadine—Agitation—Topiramate—obesity	9.88e-05	0.000697	CcSEcCtD
Amantadine—Pruritus—Bupropion—obesity	9.75e-05	0.000687	CcSEcCtD
Amantadine—Nausea—Orlistat—obesity	9.7e-05	0.000684	CcSEcCtD
Amantadine—Leukopenia—Topiramate—obesity	9.63e-05	0.000679	CcSEcCtD
Amantadine—Palpitations—Topiramate—obesity	9.5e-05	0.00067	CcSEcCtD
Amantadine—Diarrhoea—Bupropion—obesity	9.43e-05	0.000665	CcSEcCtD
Amantadine—Nausea—Sibutramine—obesity	9.39e-05	0.000662	CcSEcCtD
Amantadine—Convulsion—Topiramate—obesity	9.32e-05	0.000657	CcSEcCtD
Amantadine—Hypertension—Topiramate—obesity	9.29e-05	0.000655	CcSEcCtD
Amantadine—Anxiety—Topiramate—obesity	9.12e-05	0.000643	CcSEcCtD
Amantadine—Dizziness—Bupropion—obesity	9.11e-05	0.000642	CcSEcCtD
Amantadine—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	9.09e-05	0.000641	CcSEcCtD
Amantadine—Dry mouth—Topiramate—obesity	8.95e-05	0.000631	CcSEcCtD
Amantadine—Confusional state—Topiramate—obesity	8.85e-05	0.000624	CcSEcCtD
Amantadine—Oedema—Topiramate—obesity	8.78e-05	0.000619	CcSEcCtD
Amantadine—Vomiting—Bupropion—obesity	8.76e-05	0.000618	CcSEcCtD
Amantadine—Rash—Bupropion—obesity	8.69e-05	0.000612	CcSEcCtD
Amantadine—Dermatitis—Bupropion—obesity	8.68e-05	0.000612	CcSEcCtD
Amantadine—Headache—Bupropion—obesity	8.63e-05	0.000608	CcSEcCtD
Amantadine—Nervous system disorder—Topiramate—obesity	8.61e-05	0.000607	CcSEcCtD
Amantadine—Tachycardia—Topiramate—obesity	8.57e-05	0.000604	CcSEcCtD
Amantadine—Skin disorder—Topiramate—obesity	8.53e-05	0.000601	CcSEcCtD
Amantadine—Hyperhidrosis—Topiramate—obesity	8.49e-05	0.000598	CcSEcCtD
Amantadine—Anorexia—Topiramate—obesity	8.37e-05	0.00059	CcSEcCtD
Amantadine—Hypotension—Topiramate—obesity	8.2e-05	0.000578	CcSEcCtD
Amantadine—Nausea—Bupropion—obesity	8.18e-05	0.000577	CcSEcCtD
Amantadine—Insomnia—Topiramate—obesity	7.94e-05	0.00056	CcSEcCtD
Amantadine—Paraesthesia—Topiramate—obesity	7.88e-05	0.000556	CcSEcCtD
Amantadine—Dyspnoea—Topiramate—obesity	7.83e-05	0.000552	CcSEcCtD
Amantadine—Somnolence—Topiramate—obesity	7.8e-05	0.00055	CcSEcCtD
Amantadine—Dyspepsia—Topiramate—obesity	7.73e-05	0.000545	CcSEcCtD
Amantadine—Decreased appetite—Topiramate—obesity	7.63e-05	0.000538	CcSEcCtD
Amantadine—Gastrointestinal disorder—Topiramate—obesity	7.58e-05	0.000534	CcSEcCtD
Amantadine—Fatigue—Topiramate—obesity	7.57e-05	0.000534	CcSEcCtD
Amantadine—Constipation—Topiramate—obesity	7.51e-05	0.000529	CcSEcCtD
Amantadine—Feeling abnormal—Topiramate—obesity	7.23e-05	0.00051	CcSEcCtD
Amantadine—Body temperature increased—Topiramate—obesity	6.94e-05	0.000489	CcSEcCtD
Amantadine—Hypersensitivity—Topiramate—obesity	6.47e-05	0.000456	CcSEcCtD
Amantadine—Asthenia—Topiramate—obesity	6.3e-05	0.000444	CcSEcCtD
Amantadine—Pruritus—Topiramate—obesity	6.21e-05	0.000438	CcSEcCtD
Amantadine—Diarrhoea—Topiramate—obesity	6.01e-05	0.000423	CcSEcCtD
Amantadine—Dizziness—Topiramate—obesity	5.8e-05	0.000409	CcSEcCtD
Amantadine—Vomiting—Topiramate—obesity	5.58e-05	0.000393	CcSEcCtD
Amantadine—Rash—Topiramate—obesity	5.53e-05	0.00039	CcSEcCtD
Amantadine—Dermatitis—Topiramate—obesity	5.53e-05	0.00039	CcSEcCtD
Amantadine—Headache—Topiramate—obesity	5.5e-05	0.000388	CcSEcCtD
Amantadine—Nausea—Topiramate—obesity	5.21e-05	0.000368	CcSEcCtD
Amantadine—DRD2—GPCR downstream signaling—C3—obesity	5.88e-06	7.06e-05	CbGpPWpGaD
Amantadine—MAOB—Metabolism—ALB—obesity	5.87e-06	7.06e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—GGT1—obesity	5.85e-06	7.04e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—GOT1—obesity	5.85e-06	7.04e-05	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—obesity	5.8e-06	6.97e-05	CbGpPWpGaD
Amantadine—ABCB1—Transmembrane transport of small molecules—APOB—obesity	5.79e-06	6.97e-05	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—obesity	5.79e-06	6.96e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—NCOA1—obesity	5.77e-06	6.93e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—ACP5—obesity	5.75e-06	6.91e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—NPY—obesity	5.74e-06	6.9e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—APOC3—obesity	5.7e-06	6.85e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—IAPP—obesity	5.7e-06	6.85e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—STK11—obesity	5.68e-06	6.83e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—CYP19A1—obesity	5.68e-06	6.83e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—GCG—obesity	5.63e-06	6.77e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—SLC2A4—obesity	5.63e-06	6.77e-05	CbGpPWpGaD
Amantadine—MAOB—Metabolism—PIK3R1—obesity	5.61e-06	6.75e-05	CbGpPWpGaD
Amantadine—MAOB—Metabolism—NOS3—obesity	5.61e-06	6.75e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—G6PD—obesity	5.6e-06	6.74e-05	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—AGT—obesity	5.58e-06	6.71e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—CYCS—obesity	5.56e-06	6.69e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—SREBF2—obesity	5.53e-06	6.65e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—HK1—obesity	5.53e-06	6.65e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—CRH—obesity	5.53e-06	6.65e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—HTR1B—obesity	5.53e-06	6.65e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—SDC1—obesity	5.47e-06	6.58e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—PRKCD—obesity	5.46e-06	6.56e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—GGT1—obesity	5.46e-06	6.56e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—GOT1—obesity	5.46e-06	6.56e-05	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—obesity	5.4e-06	6.5e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—AKR1C3—obesity	5.38e-06	6.47e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—NCOA1—obesity	5.38e-06	6.46e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—LPA—obesity	5.35e-06	6.43e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—HTR2A—obesity	5.34e-06	6.42e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—C3—obesity	5.34e-06	6.41e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—STK11—obesity	5.3e-06	6.37e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—CYP19A1—obesity	5.3e-06	6.37e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—COMT—obesity	5.28e-06	6.35e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—NPS—obesity	5.25e-06	6.31e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—LPIN1—obesity	5.23e-06	6.29e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—PPARGC1A—obesity	5.21e-06	6.26e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—GNB3—obesity	5.21e-06	6.26e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—HMOX1—obesity	5.19e-06	6.24e-05	CbGpPWpGaD
Amantadine—MAOB—Metabolism—PIK3CB—obesity	5.18e-06	6.23e-05	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—PRKCB—obesity	5.16e-06	6.2e-05	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—F2—obesity	5.16e-06	6.2e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—HTR2C—obesity	5.15e-06	6.19e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—DRD1—obesity	5.15e-06	6.19e-05	CbGpPWpGaD
Amantadine—MAOB—Metabolism—PTGS2—obesity	5.13e-06	6.17e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—APOA5—obesity	5.12e-06	6.16e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—GNAS—obesity	5.07e-06	6.1e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—AGT—obesity	5.07e-06	6.09e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—NTRK2—obesity	5e-06	6.02e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—ADRB1—obesity	4.98e-06	5.99e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—APOB—obesity	4.97e-06	5.97e-05	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—PIK3CG—obesity	4.94e-06	5.94e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—COMT—obesity	4.92e-06	5.92e-05	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—obesity	4.92e-06	5.92e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—CLOCK—obesity	4.89e-06	5.88e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—SLC22A1—obesity	4.89e-06	5.88e-05	CbGpPWpGaD
Amantadine—ABCB1—Transmembrane transport of small molecules—PPARA—obesity	4.89e-06	5.88e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—PARP1—obesity	4.88e-06	5.86e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—GHRL—obesity	4.88e-06	5.86e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—PPARGC1A—obesity	4.86e-06	5.84e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—GNB3—obesity	4.86e-06	5.84e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—DRD4—obesity	4.84e-06	5.82e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—HMOX1—obesity	4.83e-06	5.81e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—SULT2A1—obesity	4.76e-06	5.73e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—GLP1R—obesity	4.76e-06	5.73e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—LPL—obesity	4.74e-06	5.7e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—GNAS—obesity	4.73e-06	5.68e-05	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—POMC—obesity	4.7e-06	5.65e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—DPYD—obesity	4.69e-06	5.64e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—F2—obesity	4.68e-06	5.63e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—PRKCB—obesity	4.68e-06	5.63e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—APOB—obesity	4.63e-06	5.57e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—GPX1—obesity	4.63e-06	5.56e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—CNR1—obesity	4.62e-06	5.55e-05	CbGpPWpGaD
Amantadine—ABCB1—Transmembrane transport of small molecules—APOA1—obesity	4.58e-06	5.51e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—TCF7L2—obesity	4.54e-06	5.46e-05	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—AKT2—obesity	4.52e-06	5.43e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—PRKAR2B—obesity	4.51e-06	5.42e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—CD36—obesity	4.51e-06	5.42e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—PIK3CG—obesity	4.48e-06	5.39e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—DCN—obesity	4.48e-06	5.39e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—GCG—obesity	4.46e-06	5.36e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—PTPN1—obesity	4.46e-06	5.36e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—LPL—obesity	4.42e-06	5.32e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—CPT1A—obesity	4.36e-06	5.24e-05	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—PIK3CD—obesity	4.34e-06	5.22e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—GPX1—obesity	4.31e-06	5.19e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—NAMPT—obesity	4.27e-06	5.14e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—MTHFR—obesity	4.27e-06	5.14e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—POMC—obesity	4.27e-06	5.13e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—PRL—obesity	4.26e-06	5.12e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—LIPC—obesity	4.25e-06	5.11e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—GCK—obesity	4.25e-06	5.11e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—APOC3—obesity	4.22e-06	5.07e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—CD36—obesity	4.2e-06	5.05e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—STK11—obesity	4.19e-06	5.04e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—PPARA—obesity	4.19e-06	5.04e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—CCL2—obesity	4.17e-06	5.02e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—PLG—obesity	4.15e-06	4.99e-05	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—RHOA—obesity	4.14e-06	4.98e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—AKT2—obesity	4.1e-06	4.93e-05	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—PIK3R1—obesity	4.1e-06	4.93e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—CETP—obesity	4.1e-06	4.93e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—AGT—obesity	4.06e-06	4.88e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—SDC1—obesity	4.05e-06	4.87e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—FOXO3—obesity	4.05e-06	4.87e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—ADRB2—obesity	4.04e-06	4.85e-05	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—obesity	4.02e-06	4.84e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—AKR1C3—obesity	3.99e-06	4.79e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—MTHFR—obesity	3.98e-06	4.79e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—APOE—obesity	3.98e-06	4.78e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—SOCS1—obesity	3.98e-06	4.78e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—PIK3CD—obesity	3.94e-06	4.74e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—CAV1—obesity	3.94e-06	4.74e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—APOA1—obesity	3.93e-06	4.73e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—SOCS3—obesity	3.93e-06	4.72e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—SCARB1—obesity	3.92e-06	4.72e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—PPARA—obesity	3.91e-06	4.7e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—GNB3—obesity	3.84e-06	4.62e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—SREBF1—obesity	3.81e-06	4.58e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—TYK2—obesity	3.79e-06	4.56e-05	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—PIK3CB—obesity	3.78e-06	4.55e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—AGT—obesity	3.78e-06	4.55e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—IGF2—obesity	3.78e-06	4.54e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—RHOA—obesity	3.76e-06	4.52e-05	CbGpPWpGaD
Amantadine—DDC—Metabolism—PIK3CA—obesity	3.75e-06	4.51e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—GNAS—obesity	3.74e-06	4.5e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—PIK3R1—obesity	3.72e-06	4.47e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—APOE—obesity	3.71e-06	4.46e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—GOT2—obesity	3.71e-06	4.45e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—CAV1—obesity	3.67e-06	4.41e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—APOB—obesity	3.67e-06	4.41e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—APOA1—obesity	3.66e-06	4.4e-05	CbGpPWpGaD
Amantadine—ABCB1—Transmembrane transport of small molecules—ALB—obesity	3.63e-06	4.37e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—FASN—obesity	3.63e-06	4.36e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—BCHE—obesity	3.61e-06	4.34e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—PIK3CG—obesity	3.59e-06	4.31e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—CCL5—obesity	3.58e-06	4.3e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—LPL—obesity	3.5e-06	4.21e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—CYP2E1—obesity	3.48e-06	4.19e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—FOXO1—obesity	3.48e-06	4.18e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—RPS6KB1—obesity	3.47e-06	4.17e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—PPARG—obesity	3.46e-06	4.16e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—NQO1—obesity	3.44e-06	4.14e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—PIK3CB—obesity	3.43e-06	4.13e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—POMC—obesity	3.42e-06	4.11e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—INS—obesity	3.4e-06	4.08e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—PIK3CG—obesity	3.34e-06	4.02e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—SLC2A4—obesity	3.3e-06	3.97e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—GCG—obesity	3.3e-06	3.97e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—CYCS—obesity	3.26e-06	3.92e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—PPARG—obesity	3.23e-06	3.88e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—PRKCD—obesity	3.23e-06	3.88e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—GGT1—obesity	3.2e-06	3.85e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—GOT1—obesity	3.2e-06	3.85e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—POMC—obesity	3.18e-06	3.83e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—INS—obesity	3.17e-06	3.81e-05	CbGpPWpGaD
Amantadine—MAOB—Metabolism—PIK3CA—obesity	3.16e-06	3.8e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—HTR2A—obesity	3.16e-06	3.79e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—PIK3CD—obesity	3.15e-06	3.79e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—C3—obesity	3.15e-06	3.79e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—NCOA1—obesity	3.15e-06	3.79e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—ALB—obesity	3.11e-06	3.74e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—STK11—obesity	3.1e-06	3.73e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—CYP19A1—obesity	3.1e-06	3.73e-05	CbGpPWpGaD
Amantadine—DDC—Metabolism—AKT1—obesity	3.07e-06	3.69e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—IRS2—obesity	3e-06	3.6e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—AGT—obesity	2.99e-06	3.6e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—PIK3R1—obesity	2.98e-06	3.58e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—NOS3—obesity	2.98e-06	3.58e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—PIK3CD—obesity	2.94e-06	3.54e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—APOE—obesity	2.93e-06	3.53e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—LEP—obesity	2.93e-06	3.53e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—CAV1—obesity	2.91e-06	3.5e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—ALB—obesity	2.9e-06	3.49e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—APOA1—obesity	2.9e-06	3.49e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—COMT—obesity	2.89e-06	3.47e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—GNB3—obesity	2.85e-06	3.42e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—PPARGC1A—obesity	2.85e-06	3.42e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—HMOX1—obesity	2.83e-06	3.41e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—ESR1—obesity	2.8e-06	3.37e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—PIK3R1—obesity	2.78e-06	3.34e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—NOS3—obesity	2.78e-06	3.34e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—GNAS—obesity	2.77e-06	3.33e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—PRKCB—obesity	2.77e-06	3.33e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—F2—obesity	2.77e-06	3.33e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—PIK3CB—obesity	2.75e-06	3.31e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—BAD—obesity	2.73e-06	3.29e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—PTGS2—obesity	2.72e-06	3.28e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—APOB—obesity	2.71e-06	3.26e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—PIK3CG—obesity	2.65e-06	3.18e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—IRS1—obesity	2.62e-06	3.15e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—LPL—obesity	2.59e-06	3.12e-05	CbGpPWpGaD
Amantadine—MAOB—Metabolism—AKT1—obesity	2.58e-06	3.1e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—PIK3CB—obesity	2.56e-06	3.08e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—PTGS2—obesity	2.54e-06	3.05e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—GPX1—obesity	2.53e-06	3.04e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—POMC—obesity	2.52e-06	3.03e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—INS—obesity	2.51e-06	3.01e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—CCL2—obesity	2.47e-06	2.97e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—CD36—obesity	2.46e-06	2.96e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—IGF1—obesity	2.42e-06	2.92e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—AKT2—obesity	2.42e-06	2.91e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—MTHFR—obesity	2.33e-06	2.81e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—PIK3CD—obesity	2.33e-06	2.8e-05	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—PIK3CA—obesity	2.31e-06	2.77e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—SERPINE1—obesity	2.3e-06	2.77e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—PPARA—obesity	2.29e-06	2.75e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—TYK2—obesity	2.24e-06	2.69e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—RHOA—obesity	2.22e-06	2.67e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—AGT—obesity	2.22e-06	2.67e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—PIK3R1—obesity	2.2e-06	2.64e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—NOS3—obesity	2.2e-06	2.64e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—APOE—obesity	2.17e-06	2.61e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—CAV1—obesity	2.15e-06	2.59e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—APOA1—obesity	2.15e-06	2.58e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—PIK3CA—obesity	2.09e-06	2.52e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—MTOR—obesity	2.03e-06	2.44e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—PIK3CB—obesity	2.03e-06	2.44e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—PIK3CG—obesity	1.96e-06	2.36e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—PPARG—obesity	1.89e-06	2.27e-05	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—AKT1—obesity	1.88e-06	2.26e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—POMC—obesity	1.87e-06	2.24e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—INS—obesity	1.86e-06	2.23e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—IL6—obesity	1.85e-06	2.23e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—MMP9—obesity	1.76e-06	2.12e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—PIK3CD—obesity	1.72e-06	2.07e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—MAPK8—obesity	1.72e-06	2.06e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—AKT1—obesity	1.71e-06	2.06e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—ALB—obesity	1.7e-06	2.05e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—PIK3CA—obesity	1.68e-06	2.02e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—PIK3R1—obesity	1.63e-06	1.96e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—NOS3—obesity	1.63e-06	1.96e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—STAT3—obesity	1.57e-06	1.89e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—PIK3CA—obesity	1.56e-06	1.88e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—PIK3CB—obesity	1.5e-06	1.81e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—PTGS2—obesity	1.49e-06	1.79e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—MYC—obesity	1.46e-06	1.75e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—TGFB1—obesity	1.45e-06	1.75e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—AKT1—obesity	1.37e-06	1.65e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—AKT1—obesity	1.28e-06	1.53e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—PIK3CA—obesity	1.24e-06	1.49e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—IL6—obesity	1.1e-06	1.32e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—AKT1—obesity	1.01e-06	1.21e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—PIK3CA—obesity	9.16e-07	1.1e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—AKT1—obesity	7.48e-07	8.99e-06	CbGpPWpGaD
